HCL Axon signs IT services deal with GlaxoSmithKline

HCL Axon, a division of HCL Technologies and a provider of SAP solutions, today said it had signed a five-year Global Strategic Information Technology Master Services Agreement with pharmaceutical major GlaxoSmithKline (GSK).

A press release from HCL said the agreement describes how HCL Axon and HCL Technologies, will provide systems integration, SAP implementation and IT consulting services to GSK globally.

It said the first activity under this agreement was to be GSK’s systems integration partner for a large SAP-enabled business transformation programme, the scope of which is in development

The release said the GSK agreement was one more major global SAP transformation win for HCL Axon since it was acquired by HCL Technologies in December last year.

"This is an important win for us," said Mr Steve Cardell, President, HCL Axon. "It keeps our strategy of becoming the largest global SAP-based business transformation provider firmly on track and confirms the rationale behind the merger with HCL."

"SAP continues to be a strategic application choice for many companies seeking to transform their business through an enterprise technology and services platform. Ensuring that such transformation programmes deliver true value needs a technology partner who understands the technology in-depth but who also truly understands business. HCL, amplified by their Axon acquisition, has a good blend of technology and business expertise to support GSK through the years ahead," Mr David Mitchell, Senior Vice-President, IT Research at analyst firm Ovum added.

NNN